PROCTER & GAMBLE HYGIENE AND HEALTH CARE LIMITED Financials Procter & Gamble Hygiene and Health Care Limited
Equities
PGHH
INE179A01014
Personal Products
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16,169 INR | +0.29% |
|
+1.40% | -6.82% |
| Mar. 26 | Analysis-In India's sizzling stock market, consumer stocks rise 18% but are laggards | RE |
| Mar. 18 | Indian Equities Start Week in Black, Aided by Major Auto and Metal Firms | MT |
Valuation
| Fiscal Period: Juni | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 347,513 | 329,642 | 432,679 | 435,092 | 464,331 | 524,845 | - | - |
| Enterprise Value (EV) 1 | 347,513 | 329,642 | 432,679 | 435,092 | 464,331 | 524,845 | 524,845 | 524,845 |
| P/E ratio | 82.9 x | - | - | - | - | 66.9 x | 60.2 x | 52.4 x |
| Yield | 0.82% | 1.03% | 1.24% | 1.19% | 1.29% | 1.48% | 1.41% | 1.57% |
| Capitalization / Revenue | 11.6 x | 11 x | 12.1 x | 11.1 x | 11.9 x | 12.7 x | 11.4 x | 10.2 x |
| EV / Revenue | 11.6 x | 11 x | 12.1 x | 11.1 x | 11.9 x | 12.7 x | 11.4 x | 10.2 x |
| EV / EBITDA | 57 x | 53.4 x | 48.5 x | 52.4 x | 53.5 x | 50.4 x | 44 x | 38.1 x |
| EV / FCF | 87.8 x | 77.9 x | 52 x | 83.1 x | 59.4 x | 114 x | 57 x | 49.9 x |
| FCF Yield | 1.14% | 1.28% | 1.92% | 1.2% | 1.68% | 0.87% | 1.75% | 2% |
| Price to Book | 38.2 x | - | 60.6 x | 59 x | - | 61.9 x | 49.2 x | 42.2 x |
| Nbr of stocks (in thousands) | 32,461 | 32,461 | 32,461 | 32,461 | 32,461 | 32,461 | - | - |
| Reference price 2 | 10,706 | 10,155 | 13,329 | 13,404 | 14,304 | 16,169 | 16,169 | 16,169 |
| Announcement Date | 8/21/19 | 8/25/20 | 8/25/21 | 8/23/22 | 8/28/23 | - | - | - |
1INR in Million2INR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: June | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 29,998 | 30,020 | 35,741 | 39,252 | 39,179 | 41,308 | 46,099 | 51,639 |
| EBITDA 1 | 6,092 | 6,176 | 8,919 | 8,299 | 8,686 | 10,422 | 11,928 | 13,778 |
| EBIT 1 | 5,595 | - | 8,443 | 7,770 | - | 9,567 | 11,226 | 12,854 |
| Operating Margin | 18.65% | - | 23.62% | 19.8% | - | 23.16% | 24.35% | 24.89% |
| Earnings before Tax (EBT) 1 | 6,073 | - | 8,699 | 7,901 | 8,395 | 10,543 | 11,654 | 13,401 |
| Net income 1 | 4,191 | - | 6,518 | 5,758 | 6,781 | 7,656 | 8,719 | 10,026 |
| Net margin | 13.97% | - | 18.24% | 14.67% | 17.31% | 18.53% | 18.91% | 19.42% |
| EPS 2 | 129.1 | - | - | - | - | 241.7 | 268.4 | 308.7 |
| Free Cash Flow 1 | 3,957 | 4,230 | 8,315 | 5,233 | 7,814 | 4,585 | 9,209 | 10,513 |
| FCF margin | 13.19% | 14.09% | 23.26% | 13.33% | 19.94% | 11.1% | 19.98% | 20.36% |
| FCF Conversion (EBITDA) | 64.95% | 68.5% | 93.23% | 63.06% | 89.95% | 43.99% | 77.2% | 76.3% |
| FCF Conversion (Net income) | 94.42% | - | 127.57% | 90.89% | 115.22% | 59.89% | 105.62% | 104.86% |
| Dividend per Share 2 | 88.00 | 105.0 | 165.0 | 160.0 | 185.0 | 238.5 | 228.5 | 254.0 |
| Announcement Date | 8/21/19 | 8/25/20 | 8/25/21 | 8/23/22 | 8/28/23 | - | - | - |
1INR in Million2INR
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: June | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 7,744 | 7,866 | 10,583 | 10,930 | 9,733 | 7,820 | 10,449 | 11,374 | 8,831 | 8,525 | - | 12,398 | 9,464 | 9,262 |
| EBITDA 1 | 1,363 | 748.8 | 3,071 | 2,965 | 1,650 | 670.9 | 2,140 | 2,905 | 1,493 | 2,149 | - | 3,200 | 2,116 | 2,415 |
| EBIT | - | - | - | - | - | - | - | - | - | - | - | - | 2,069 | 1,952 |
| Operating Margin | - | - | - | - | - | - | - | - | - | - | - | - | 21.86% | 21.08% |
| Earnings before Tax (EBT) 1 | 1,292 | 672.5 | - | 2,875 | 1,511 | 577 | - | 2,815 | 1,456 | 2,066 | - | 3,148 | 1,990 | 2,338 |
| Net income 1 | 983.3 | 489.8 | - | 2,121 | 1,028 | 425.5 | - | 2,075 | 1,650 | 1,512 | 2,107 | 2,380 | 1,526 | 1,758 |
| Net margin | 12.7% | 6.23% | - | 19.4% | 10.57% | 5.44% | - | 18.24% | 18.69% | 17.74% | - | 19.2% | 16.13% | 18.99% |
| EPS | - | - | - | - | - | - | - | - | - | - | 64.91 | - | 49.30 | 46.60 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 5/4/21 | 8/25/21 | 11/2/21 | 2/1/22 | 4/28/22 | 8/23/22 | 11/2/22 | 1/31/23 | 5/10/23 | 8/28/23 | 10/30/23 | - | - | - |
1INR in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: June | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - | - | - | - |
| Net Cash position | - | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
| Free Cash Flow 1 | 3,957 | 4,230 | 8,315 | 5,233 | 7,814 | 4,585 | 9,209 | 10,513 |
| ROE (net income / shareholders' equity) | 48.9% | 43.2% | 69.6% | 79.3% | 80.6% | 81.4% | 88.1% | 88.2% |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - | - | - |
| Book Value Per Share 2 | 280.0 | - | 220.0 | 227.0 | - | 261.0 | 328.0 | 383.0 |
| Cash Flow per Share | - | - | - | - | - | - | - | - |
| Capex 1 | 161 | - | 316 | - | 444 | 986 | 699 | 686 |
| Capex / Sales | 0.54% | - | 0.88% | - | 1.13% | 2.39% | 1.52% | 1.33% |
| Announcement Date | 8/21/19 | 8/25/20 | 8/25/21 | 8/23/22 | 8/28/23 | - | - | - |
1INR in Million2INR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
C
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -6.82% | 6.29B | |
| +8.76% | 129B | |
| +14.18% | 74.67B | |
| -16.59% | 62.59B | |
| +0.82% | 52.86B | |
| -12.40% | 36.11B | |
| +3.54% | 33.57B | |
| +7.92% | 17.29B | |
| +6.30% | 14.75B | |
| -8.65% | 10.82B |
- Stock Market
- Equities
- PGHH Stock
- Financials Procter & Gamble Hygiene and Health Care Limited
